Natus to Participate in the 20th Annual Needham Virtual Healthcare Conference
Natus Medical Incorporated (NASDAQ: NTUS) announced its participation in the 20th Annual Needham Virtual Healthcare Conference on April 15, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Natus Medical Incorporated (NASDAQ: NTUS) announced its participation in the 20th Annual Needham Virtual Healthcare Conference on April 15, 2021. During the event, CEO Jonathan Kennedy and CFO Drew Davies will present from 3:00 p.m. to 3:40 p.m. Eastern Time, followed by one-on-one meetings with institutional investors. Interested investors can schedule meetings through Needham representatives. The presentation will be available live and archived for 90 days on Natus’ Investor Relations website.
Details
News Market Reaction – NTUS
The recorded move for NTUS in the trading session of this news was +1.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonathan Kennedy, President and Chief Executive Officer and Drew Davies, Executive Vice President and Chief Financial Officer will be presenting from 3:00 p.m. to 3:40 p.m. Eastern Time and hosting one-on-one meetings during the day with institutional investors at the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15th.
Investors interested in scheduling a meeting should contact a Needham representative. The presentation will be webcast live and archived for 90 days on Natus’ Investor Relations website at https://investor.natus.com/.
About Natus Medical Incorporated
Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Additional information about Natus Medical can be found at www.natus.com.
Contacts:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.